Global Payments Other Non-Current Liabilities increased by 113.5% to $1.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 67.4%, from $666.07M to $1.11B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -7.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $829.25M | $824.68M | $739.05M | $723.50M | $703.01M | $655.13M | $647.98M | $699.41M | $693.52M | $672.75M | $722.54M | $644.00M | $639.18M | $672.90M | $550.45M | $666.07M | $577.45M | $555.87M | $522.12M | $1.11B |
| QoQ Change | — | -0.6% | -10.4% | -2.1% | -2.8% | -6.8% | -1.1% | +7.9% | -0.8% | -3.0% | +7.4% | -10.9% | -0.7% | +5.3% | -18.2% | +21.0% | -13.3% | -3.7% | -6.1% | +113.5% |
| YoY Change | — | — | — | — | -15.2% | -20.6% | -12.3% | -3.3% | -1.3% | +2.7% | +11.5% | -7.9% | -7.8% | +0.0% | -23.8% | +3.4% | -9.7% | -17.4% | -5.1% | +67.4% |